Recombinant Coagulation Factor VIIa for rapid preoperative correction of Warfarin-related coagulopathy in patients with acute subdural hematoma

Medical Science Monitor

Volumn 8, Issue 12, 2002, Pages

  Veshchev, Igor ^a   Elran, Hanoch ^a   Salame, Khalil ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Anticoagulation; Craniotomy; Intracranial hemorrhage; Recombinant coagulation factor VIIa

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP; WARFARIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BRAIN HEMORRHAGE; CASE REPORT; CRANIOTOMY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HEMOSTASIS; HUMAN; MALE; PREOPERATIVE PERIOD; SUBDURAL HEMATOMA;

CRANIOTOMY; FACTOR VIIA; HEART VALVE PROSTHESIS; HEMATOMA, SUBDURAL, ACUTE; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RECOMBINANT PROTEINS; WARFARIN;

EID: 0036962116     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mathiesen T, Benediktsdottir K, Lindqvist M, von Holst H: Intracranial traumatic and non-traumatic hemorrhagic complications of warfarin treatment. Acta Neurol Scand, 1995; 91: 208-214
2. Boulis N, Bobck M, Sclnnaier A, Hoff J: Use of factor IX complex in Warfarin-related intracranial hemorrhage. Neurosurgery, 1999; 45(5): 1113-1119
3. Kawamata T, Takeshita M, Kubo O et al: Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol, 1995; 44: 438-443
4. Fredriksson K, Norrving B, Strömblad L-G: Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke, 1992; 23(7): 972-977
5. Kohler M, Hellstern P, Lechler E et al: Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates. Thromb Haemost, 1998; 80(3): 399-402
6. Arkin S et al: Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Haemostasis, 1998; 28: 93-98
7. Blatt J, Gold SII, Wiley JM et al: Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplant, 2001; 28(4): 405-407
8. Vidarsson B, Onundarson PT: Recobinant factor VIIa for bleeding in refractory thrombocytopenia. Thromb Haemost, 2000; 83(4): 634-635
9. Wong WY, Huang WC, Miller R et al: Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial hemorrhage in severe neonatal FVII deficiency. Haemophilia, 2000; 6: 50-54, 2000
10. Talstad I: Which coagulation factors interfere with the one-stage prothrombin time? Haemostasis, 1993; 23: 19-25
11. Erhardtsen E, Nony P, Dechavanne M et al: The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis, 1998; 9: 741-748
12. Berntrop E: Recombinant VIIa in the treatment of Warfarin bleeding. Seminars in Thrombosis and Hemostasis, 2000; 26(4): 433-435